Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | SLC9A1 | P19634 | 6/20 | 0.51 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | TDO2 | P48775 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | APAF1 | O14727 | 1/20 | 0.45 |
| ▸ | TDP2 | O95551 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9137840 | 0.89 | CYP2D6 (0.79) | CYP2D6SLC9A1GRM2NPC1MAPT | |
| SCHEMBL4340679 | 0.85 | CYP2D6 (0.74) | CYP2D6SLC9A1GRM2NPC1MAPT | |
| SCHEMBL10625061 | 0.84 | CYP2D6 (0.72) | CYP2D6SLC9A1GRM2NPC1MAPT | |
| SCHEMBL11208551 | 0.81 | CYP2D6 (0.68) | CYP2D6SLC9A1GRM2NPC1MAPT | |
| SCHEMBL31234269 | 0.79 | SLC9A1 (0.70) | CYP2D6SLC9A1GRM2NPC1MAPT | |
| SCHEMBL1774497 | 0.79 | SLC9A1 (0.70) | CYP2D6SLC9A1GRM2NPC1MAPT | |
| SCHEMBL11536847 | 0.79 | CYP2D6 (0.65) | CYP2D6SLC9A1GRM2NPC1MAPT | |
| SCHEMBL242196 | 0.76 | CYP2D6 (0.60) | CYP2D6SLC9A1NPC1MAPTLMNA | |
| SCHEMBL8645936 | 0.74 | POLB (0.58) | CYP2D6SLC9A1NPC1MAPTLMNA | |
| SCHEMBL29479909 | 0.73 | SLC9A1 (0.67) | CYP2D6SLC9A1GRM2NPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2014797-A2 | Coating composition for interconnection part of electrode and plasma display panel including the same | Samsung SDI Co., Ltd. (KR) | 2009-01-14 | — | — | EP | claimed |
| US-20080303439-A1 | Coating composition for interconnection part of electrode and plasma display panel including the same | SAMSUNG SDI CO., LTD., A CORP. OF THE REPUBLIC OF KOREA (KR) | 2008-12-11 | — | — | US | claimed |
| EP-2206707-B1 | AZOLECARBOXAMIDE COMPOUND OR SALT THEREOF | ASTELLAS PHARMA INC (JP) | 2014-07-23 | — | — | EP | disclosed |
| US-8330039-B2 | Solar cell modules with poly(vinyl butyral) encapsulant comprising unsaturated heterocyclic compound | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-11 | — | — | US | disclosed |
| US-8304547-B2 | Azolecarboxamide compound or salt thereof | ASTELLAS PHARMA INC. (JP) | 2012-11-06 | — | — | US | disclosed |
| CN-101835764-B | Azolecarboxamide compound or salt thereof | ASTELLAS PHARMA INC | 2012-09-19 | — | — | CN | disclosed |
| EP-2380208-A1 | SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND | E. I. du Pont de Nemours and Company (US) | 2011-10-26 | — | — | EP | disclosed |
| US-20100249088-A1 | AZOLECARBOXAMIDE COMPOUND OR SALT THEREOF | ASTELLAS PHARMA INC. (JP) | 2010-09-30 | — | — | US | disclosed |
| CN-101835764-A | Azolecarboxamide compound or salt thereof | ASTELLAS PHARMA INC | 2010-09-15 | — | — | CN | disclosed |
| WO-2010085664-A1 | SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-29 | — | — | WO | disclosed |
| US-20100180947-A1 | SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-22 | — | — | US | disclosed |
| US-7306894-B2 | Polymerizable composition, photopolymerizing method and process for producing lithographic printing plate using the polymerizable composition | FUJIFILM CORPORATION (JP) | 2007-12-11 | — | — | US | disclosed |
| US-7306894-B2 | Polymerizable composition, photopolymerizing method and process for producing lithographic printing plate using the polymerizable composition | FUJIFILM CORPORATION (JP) | 2007-12-11 | — | — | US | disclosed |
| US-20050282387-A1 | Metal polish composition, polishing method using the composition and method for producing wafer using the polishing method | SHOWA DENKO K.K. (JP) | 2005-12-22 | — | — | US | disclosed |
| EP-0395185-A1 | Curing catalyst for application in powder coatings | DSM N.V. (NL) | 1990-10-31 | — | — | EP | disclosed |
| EP-0205398-B1 | ADDITIVE FOR FUNCTIONAL FLUIDS | CIBA-GEIGY AG (CH) | 1989-11-08 | — | — | EP | disclosed |
| US-4791206-A | METAL PASSIVATING, OXIDATION RESISTANCE | CIBA-GEIGY CORPORATION (US) | 1988-12-13 | — | — | US | disclosed |
| EP-0044277-B1 | PRINTING INK AND ITS USE IN THE MANUFACTURE OF TEXTURED, FOAMED RESINOUS MATERIALS | CIBA-GEIGY AG (CH) | 1985-08-28 | — | — | EP | disclosed |
| US-4407882-A | FOAMING INHIBITOR | CIBA-GEIGY CORPORATION (US) | 1983-10-04 | — | — | US | disclosed |
| EP-0044277-A2 | Printing ink and its use in the manufacture of textured, foamed resinous materials | CIBA-GEIGY AG (CH) | 1982-01-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249088-A1 | AZOLECARBOXAMIDE COMPOUND OR SALT THEREOF | TRPV1, FGFR3, GPR17 | CYP2D6 4646/4885SLC9A1 1854/4885GRM2 2555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.